Vertex seeks partner for flu drug after positive trial
This article was originally published in Scrip
Executive Summary
Vertex Pharmaceuticals said an experimental flu drug worked in a Phase II trial and the company will seek a partner to help take the therapy into late-stage studies for possible market approval.